Filter
31
Filtered Results: 31
Text search:
Drugs
for
Neglected
Diseases
Initiative
DNDi
Latin
America
Featured
Recommendations
2
Language
Document type
Studies & Reports
18
Strategic & Response Plan
3
Manuals
2
Brochures
2
Guidelines
2
Fact sheets
2
Resource Platforms
1
No document type
1
Countries / Regions
Latin America and the Carribbean
7
Colombia
3
Global
3
Brazil
1
Authors & Publishers
Publication Years
Category
Countries
7
Clinical Guidelines
4
Pharmacy & Technologies
1
Toolboxes
NTDs
28
HIV
1
COVID-19
1
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
The Lancet Microbe Series Chagas Disease 2 Volume 5, Issue 10100946 October 2024
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
Front. Trop. Dis. , 09 May 2023 Sec. Neglected Tropical Diseases Volume 4 - 2023 | https://doi.org/10.3389/fitd.2023.1087003
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Rev Panam Salud Publica 2023;47:e141. https://doi.org/10.26633/RPSP.2023.141
